1 SEC 13D/G filing tracked · Last updated Oct 4, 2026
$GMAB Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients…
